• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Unapproved Drugs: Firm Actions

Since publication of the CPG, the Agency has taken enforcement actions against a number of firms with significant violations of current good manufacturing practice (CGMPs) or adverse event reporting requirements that also make unapproved drugs.

 

Abraxis Bioscience, Inc.

 

Actavis Totowa, LLC

 

Amerifit Brands, Inc.

 

ANIP Acquisition Company

 

Bryant Ranch Prepac

 

Claris Lifesciences Limited

 

Concord Laboratories, Inc.

 

Contract Pharmacal Corporation

 

C. R. Canfield Co., Inc.

 

Deltex Pharmaceuticals Inc.

 

Deston Therapeutics

Elge, Inc.

 

G & W Laboratories, Inc.

 

Hi-Tech Pharmacal Co., Inc.

 

Hill Dermaceuticals, Inc.

 

IriSys, Inc.

 

Keystone Pharmaceuticals

 

KV Pharmaceutical Company

 

McGuff Pharmaceuticals, Inc.

 

Midland Pharmaceutical LLC

 

Neil Laboratories, Inc.

 

Neilgen Pharmaceuticals, Inc.

 

Nexgen Pharma, Inc.

 

Ohm Laboratories, Inc.

 

PharmaFab Inc.


Pharmakon Laboratory, Inc.

 

Pharma Pac Inc.

 

PrimaPharm Inc.

 

Provident Pharmaceuticals LLC

 

River's Edge Pharmaceuticals, LLC

 

RGH & Company Inc., dba Vital Nutrients

 

Scientific Laboratories, Inc.

 

Sheffield Laboratories, Division of Faria Limited LLC

 

Sunrise Pharmaceutical, Inc.

 

Syntho Pharmaceuticals, Inc. and Intermax Pharmaceuticals, Inc.

 

Time-Cap Laboratories, Inc.

 

Tri-Med Laboratories, Inc.

  • Warning Letter (February 23, 2010)
  • Consent Decree of Permanent Injunction (PDF - ) (March 2011)

 

Vintage Pharmaceuticals, LLC

 

Vita-Erb, Ltd.

 

-
-